Ruminants Health
Ruminants
Search
More Green
More Green
Boehringer Ingelheim recognised as Top Employer for 2024
Boehringer Ingelheim Recognised as Top Employer for 2024, Demonstrating Strong Commitment to People Development in Australia and New Zealand
Accelerating gender equality at Boehringer Ingelheim
Accelerating gender equality at Boehringer Ingelheim
Retinal Diseases
Retinal Diseases
Fostering Science
Fostering Science
Boehringer Ingelheim | Boehringer Ingelheim ANZ
Boehringer Ingelheim is one of the world’s leading family-owned pharmaceutical companies, developing medicines to address unmet needs in human and animal health.
Science Focus
Science Focus
Our Responsibility
Human Health Our Responsibility
Sustainable Development
Sustainable Development
The Angels Initiative Surpasses 1,000 Registrations for Acute Stroke Training
Global program equips HCPs for optimal acute stroke treatment
Heart Diseases
Heart Diseases
Keith's Journey with Heart of Australia
Rural and remote medical needs in Australia
TOP Employer 2023
TOP Employer 2023
Empowering independence with Guide Dogs
Empowering independence with Guide Dogs
He’s my dog, I’m his human
Getting a Guide Dog was a life-changing moment for Lucy, who lost her sight in a car accident as a teenager.
Drug Discovery at Boehringer Ingelheim
Find out more about the drug discovery process at Boehringer Ingelheim